ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2153

Clinical Characteristics and Outcomes in Synovial Fluid Culture ̵ Negative Septic Arthritis

Sarah B. Lieber, Ziv Paz and Robert H. Shmerling, Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Bacterial infections, outcomes, surgery and synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Title: Infections, Infection-related Biomarkers and Impact of Biologic Therapies

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Delays in diagnosis and treatment of septic arthritis may be associated with significant morbidity. While many patients with suspected or proven septic arthritis are treated surgically, aggressive surgical intervention may be unnecessary when the diagnosis is not secure. This includes patients with negative synovial fluid cultures, representing up to 40% of patients with clinically suspected septic arthritis. We aim to characterize patients with presumed septic arthritis who were treated surgically, but who had negative synovial fluid cultures. This may help predict which patients could be treated safely without surgical intervention.

Methods:

We conducted a restrospective cohort study of patients 18 years and older admitted to a single tertiary care center from January 2010 to May 2014 with a presumptive diagnosis of septic arthritis leading to operative management. Patients were stratified into culture-positive and culture-negative groups based on synovial fluid testing. Length of hospital stay (LOHS) was designated as the primary outcome. Secondary outcomes included 60 ̵ day readmission rate and establishment of an alternative diagnosis to explain the index admission within a year of discharge.

Results:

Of 208 patients with clinically suspected septic arthritis who underwent surgical intervention, 90 (43.3%) were synovial fluid culture ̵positive. The culture ̵ positive and culture ̵ negative groups were similar with respect to gender (approximately half were female), age (mean of 63 years), frequency of prosthetic joint involvement (about 60%), and frequency of knee involvement (about 60%). For the culture-positive group, mean LOHS and 60 ̵ day readmission rate were 11.4 days and 26.7%, respectively; in the culture-negative group, mean LOHS and 60-day readmission rate were 9.9 days and 36.4%, respectively (p = 0.09 for LOHS; p = 0.18 for 60-day readmission rate). An alternative diagnosis to explain the index admission was made in 3 (3.3%) cases in the culture ̵positive group and in 10 (9.3%) cases in the culture ̵ negative group (p = 0.16). Among patients with native joints, mean LOHS, 60-day readmission rate, and frequency of alternative diagnosis did not differ significantly between the culture ̵ positive and culture ̵ negative groups.

Conclusion:

In our medical center, the majority of patients with clinically suspected septic arthritis managed operatively had negative synovial fluid cultures at the time of diagnosis. While those with positive and negative synovial fluid cultures had similar baseline features, we observed a trend toward shorter length of hospital stay and more alternative diagnoses in the culture-negative group. The inclusion of additional presenting features (currently underway), including the presence of comorbidities, prior use of antibiotics, systemic signs of infection, and synovial fluid characteristics, may identify a subset of patients with suspected septic arthritis who may be managed safely without surgery.


Disclosure:

S. B. Lieber,
None;

Z. Paz,
None;

R. H. Shmerling,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-and-outcomes-in-synovial-fluid-culture-%cc%b5-negative-septic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology